{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:03:07Z","timestamp":1770415387304,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/pr.2016.199","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T16:23:50Z","timestamp":1475598230000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease"],"prefix":"10.1038","volume":"81","author":[{"given":"Thomas G.","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Czinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"BFpr2016199_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/0140-6736(93)90938-D","volume":"341","author":"Eurogast Study Group.","year":"1993","unstructured":"Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359\u201362.","journal-title":"Lancet"},{"key":"BFpr2016199_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","volume":"1","author":"BJ Marshall","year":"1984","unstructured":"Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311\u20135.","journal-title":"Lancet"},{"key":"BFpr2016199_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","volume":"272","author":"NIH Consensus Conference.","year":"1994","unstructured":"NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994;272:65\u201369.","journal-title":"J Am Med Assoc"},{"key":"BFpr2016199_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127\u201331.","journal-title":"N Engl J Med"},{"key":"BFpr2016199_CR5","unstructured":"World Health Organization. Infection with Helicobacter pylori. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer, 1994; 177\u2013241."},{"key":"BFpr2016199_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/0016-5085(91)90644-Z","volume":"100","author":"DY Graham","year":"1991","unstructured":"Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterol 1991;100:1495\u2013501.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR7","unstructured":"World Gastroenterology Organization. Global Guidelines: Helicobacter pylori in developing countries, 2010. ( http:\/\/www.worldgastroenterology.org\/UserFiles\/file\/guidelines\/helicobacter-pylori-english-2010.pdf .)."},{"key":"BFpr2016199_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2169\/internalmedicine.47.0975","volume":"47","author":"Y Yamaoka","year":"2008","unstructured":"Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008;47:1077\u201383.","journal-title":"Intern Med"},{"key":"BFpr2016199_CR9","first-page":"469","volume":"27","author":"LS Doenges","year":"1939","unstructured":"Doenges LS. Spirochetes in the gastric glands of Macacus rhesus and of man without related disease. Arch Pathol 1939;27:469\u201377.","journal-title":"Arch Pathol"},{"key":"BFpr2016199_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF02997393","volume":"7","author":"AS Freedberg","year":"1940","unstructured":"Freedberg AS, Barron LE. The presence of spirochetes in human gastric mucosa. Am J Dig Dis 1940;7:443\u201345.","journal-title":"Am J Dig Dis"},{"key":"BFpr2016199_CR11","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1055\/s-0028-1142055","volume":"32","author":"W Krienitz","year":"1906","unstructured":"Krienitz W. Ueber das auftreten von mageninhalt bei carcinoma ventriculi. Dtsch Med Wochenschr 1906;32:872.","journal-title":"Dtsch Med Wochenschr"},{"key":"BFpr2016199_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/gut.16.8.590","volume":"16","author":"HW Steer","year":"1975","unstructured":"Steer HW, Colin-Jones DG. Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut 1975;16:590\u20137.","journal-title":"Gut"},{"key":"BFpr2016199_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0016-5085(19)36173-6","volume":"27","author":"ED Palmer","year":"1954","unstructured":"Palmer ED. Investigation of the gastric mucosa spirochetes of the human. Gastroenterol 1954;27:218\u201320.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR14","first-page":"1273","volume":"I","author":"JR Warren","year":"1983","unstructured":"Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. The Lancet 1983;I:1273\u201375.","journal-title":"The Lancet"},{"key":"BFpr2016199_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","volume":"142","author":"BJ Marshall","year":"1985","unstructured":"Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch\u2019s postulates for pyloric Campylobacter. Med J Aust 1985;142:436\u20139.","journal-title":"Med J Aust"},{"key":"BFpr2016199_CR16","first-page":"192","volume":"82","author":"A Morris","year":"1987","unstructured":"Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987;82:192\u20139.","journal-title":"Am J Gastroenterol"},{"key":"BFpr2016199_CR17","first-page":"37","volume-title":"The Burden of Digestive Diseases in the United States","author":"CE Ruhl","year":"2008","unstructured":"Ruhl CE, Sayer B, Byrd-Holt DD, Brown DM. Costs of digestive diseases. In: Everhart JE, ed. The Burden of Digestive Diseases in the United States. US Department of Health and Human Services, Public Health Service, national Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, D.C.: US Government Printing Office, 2008:37\u2013147."},{"key":"BFpr2016199_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(86)91120-7","volume":"1","author":"S Cadranel","year":"1986","unstructured":"Cadranel S, Goossens H, De Boeck M, Malengreau A, Rodesch P, Butzler JP. Campylobacter pyloridis in children. Lancet 1986;1:735\u20136.","journal-title":"Lancet"},{"key":"BFpr2016199_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0022-3476(86)80579-0","volume":"109","author":"SJ Czinn","year":"1986","unstructured":"Czinn SJ, Dahms BB, Jacobs GH, Kaplan B, Rothstein FC. Campylobacter-like organisms in association with symptomatic gastritis in children. J Pediatr 1986;109:80\u20133.","journal-title":"J Pediatr"},{"key":"BFpr2016199_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(86)92353-6","volume":"1","author":"R Hill","year":"1986","unstructured":"Hill R, Pearman J, Worthy P, Caruso V, Goodwin S, Blincow E. Campylobacter pyloridis and gastritis in children. Lancet 1986;1:387.","journal-title":"Lancet"},{"key":"BFpr2016199_CR21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJM198706183162501","volume":"316","author":"B Drumm","year":"1987","unstructured":"Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987;316:1557\u201361.","journal-title":"N Engl J Med"},{"key":"BFpr2016199_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterol 2016;151:51\u201369.e14.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1523-5378.2011.00931.x","volume":"17","author":"LA Fischbach","year":"2012","unstructured":"Fischbach LA, Nordenstedt H, Kramer JR, et al. The association between Barrett\u2019s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 2012;17:163\u201375.","journal-title":"Helicobacter"},{"key":"BFpr2016199_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","volume":"5","author":"T Rokkas","year":"2007","unstructured":"Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007;5:1413\u20137, 1417.e1\u20132.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFpr2016199_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cgh.2013.08.029","volume":"12","author":"JH Rubenstein","year":"2014","unstructured":"Rubenstein JH, Inadomi JM, Scheiman J, et al. Association between Helicobacter pylori and Barrett\u2019s esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014;12:239\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFpr2016199_CR26","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1053\/j.gastro.2010.08.018","volume":"139","author":"A Sonnenberg","year":"2010","unstructured":"Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterol 2010;139:1894\u20131901.e2; quiz e12.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2011.06.081","volume":"141","author":"ES Dellon","year":"2011","unstructured":"Dellon ES, Peery AF, Shaheen NJ, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterol 2011;141:1586\u201392.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ibd.21116","volume":"16","author":"J Luther","year":"2010","unstructured":"Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010;16:1077\u201384.","journal-title":"Inflamm Bowel Dis"},{"key":"BFpr2016199_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archinte.167.8.821","volume":"167","author":"Y Chen","year":"2007","unstructured":"Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167:821\u20137.","journal-title":"Arch Intern Med"},{"key":"BFpr2016199_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1086\/590158","volume":"198","author":"Y Chen","year":"2008","unstructured":"Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553\u201360.","journal-title":"J Infect Dis"},{"key":"BFpr2016199_CR31","doi-asserted-by":"publisher","first-page":"e4060","DOI":"10.1371\/journal.pone.0004060","volume":"3","author":"J Reibman","year":"2008","unstructured":"Reibman J, Marmor M, Filner J, et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008;3:e4060.","journal-title":"PLoS One"},{"key":"BFpr2016199_CR32","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1172\/JCI45041","volume":"121","author":"IC Arnold","year":"2011","unstructured":"Arnold IC, Dehzad N, Reuter S, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011;121:3088\u201393.","journal-title":"J Clin Invest"},{"key":"BFpr2016199_CR33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1172\/JCI61029","volume":"122","author":"M Oertli","year":"2012","unstructured":"Oertli M, Sundquist M, Hitzler I, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012;122:1082\u201396.","journal-title":"J Clin Invest"},{"key":"BFpr2016199_CR34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/MMBR.56.4.622-647.1992","volume":"56","author":"BD Spangler","year":"1992","unstructured":"Spangler BD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 1992;56:622\u201347.","journal-title":"Microbiol Rev"},{"key":"BFpr2016199_CR35","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.132.6.2736","volume":"132","author":"CO Elson","year":"1984","unstructured":"Elson CO, Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984;132:2736\u201341.","journal-title":"J Immunol"},{"key":"BFpr2016199_CR36","first-page":"301","volume":"59","author":"N Lycke","year":"1986","unstructured":"Lycke N, Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986;59:301\u20138.","journal-title":"Immunology"},{"key":"BFpr2016199_CR37","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.4049\/jimmunol.139.10.3484","volume":"139","author":"JG Nedrud","year":"1987","unstructured":"Nedrud JG, Liang XP, Hague N, Lamm ME. Combined oral\/nasal immunization protects mice from Sendai virus infection. J Immunol 1987;139:3484\u201392.","journal-title":"J Immunol"},{"key":"BFpr2016199_CR38","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/IAI.59.7.2359-2363.1991","volume":"59","author":"SJ Czinn","year":"1991","unstructured":"Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359\u201363.","journal-title":"Infect Immun"},{"key":"BFpr2016199_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0016-5085(90)91016-Y","volume":"99","author":"JG Fox","year":"1990","unstructured":"Fox JG, Correa P, Taylor NS, et al. Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterol 1990;99:352\u201361.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR40","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/0016-5085(90)91156-Z","volume":"99","author":"A Lee","year":"1990","unstructured":"Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterol 1990;99:1315\u201323.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0264-410X(93)90309-L","volume":"11","author":"SJ Czinn","year":"1993","unstructured":"Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993;11:637\u201342.","journal-title":"Vaccine"},{"key":"BFpr2016199_CR42","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/0140-6736(92)90720-N","volume":"339","author":"M Chen","year":"1992","unstructured":"Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse\/Helicobacter felis model. Lancet 1992;339:1120\u20131.","journal-title":"Lancet"},{"key":"BFpr2016199_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1079\/9781845935948.0167","volume-title":"Helicobacter Pylori in the 21st Century","author":"T Blanchard","year":"2010","unstructured":"Blanchard T, Nedrud J. Helicobacter pylori vaccines. In: Sutton P, Hazel M eds. Helicobacter Pylori in the 21st Century. Wallingford, UK: CABI, 2010:167\u2013189."},{"key":"BFpr2016199_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0016-5085(95)90275-9","volume":"109","author":"I Corth\u00e9sy-Theulaz","year":"1995","unstructured":"Corth\u00e9sy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterol 1995;109:115\u201321.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR45","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1053\/gast.1996.v110.pm8964402","volume":"110","author":"R Cuenca","year":"1996","unstructured":"Cuenca R, Blanchard TG, Czinn SJ, et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterol 1996;110:1770\u20135.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(94)90032-9","volume":"343","author":"C Doidge","year":"1994","unstructured":"Doidge C, Crust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunisation against Helicobacter infection. Lancet 1994;343:914\u20135.","journal-title":"Lancet"},{"key":"BFpr2016199_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","volume":"116","author":"P Michetti","year":"1999","unstructured":"Michetti P, Kreiss C, Kotloff KL, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterol 1999;116:804\u201312.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR48","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/0016-5085(94)90224-0","volume":"107","author":"P Michetti","year":"1994","unstructured":"Michetti P, Corth\u00e9sy-Theulaz I, Davin C, et al. Immunization of BALB\/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterol 1994;107:1002\u201311.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/gut.51.5.634","volume":"51","author":"S Banerjee","year":"2002","unstructured":"Banerjee S, Medina-Fatimi A, Nichols R, et al. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut 2002;51:634\u201340.","journal-title":"Gut"},{"key":"BFpr2016199_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0264-410X(02)00467-X","volume":"21","author":"S Sougioultzis","year":"2002","unstructured":"Sougioultzis S, Lee CK, Alsahli M, et al. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine 2002;21:194\u2013201.","journal-title":"Vaccine"},{"key":"BFpr2016199_CR51","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","volume":"69","author":"KL Kotloff","year":"2001","unstructured":"Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 2001;69:3581\u201390.","journal-title":"Infect Immun"},{"key":"BFpr2016199_CR52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/gut.2007.145839","volume":"57","author":"T Aebischer","year":"2008","unstructured":"Aebischer T, Bumann D, Epple HJ, et al. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 2008;57:1065\u201372.","journal-title":"Gut"},{"key":"BFpr2016199_CR53","doi-asserted-by":"publisher","first-page":"S-184","DOI":"10.1016\/S0016-5085(12)60689-1","volume":"142","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Selgrad M, Wex T, et al. Efficacy of an investigational recombinant antigen based vaccine against a CagA H. pylori infectious challenge in healthy volunteers. Gastroenterol 2012;142:S-184.","journal-title":"Gastroenterol"},{"key":"BFpr2016199_CR54","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","volume":"386","author":"M Zeng","year":"2015","unstructured":"Zeng M, Mao XH, Li JX, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2015;386:1457\u201364.","journal-title":"Lancet"},{"key":"BFpr2016199_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/oxfordjournals.bmb.a011678","volume":"54","author":"RA Feldman","year":"1998","unstructured":"Feldman RA, Eccersley AJ, Hardie JM. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br Med Bull 1998;54:39\u201353.","journal-title":"Br Med Bull"},{"key":"BFpr2016199_CR56","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/gut.2003.037499","volume":"53","author":"DY Graham","year":"2004","unstructured":"Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004;53:1235\u201343.","journal-title":"Gut"},{"key":"BFpr2016199_CR57","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1073\/pnas.92.14.6499","volume":"92","author":"RL Ferrero","year":"1995","unstructured":"Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995;92:6499\u2013503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2016199_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2567.1998.00482.x","volume":"94","author":"TG Blanchard","year":"1998","unstructured":"Blanchard TG, Lycke N, Czinn SJ, Nedrud JG. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Immunology 1998;94:22\u20137.","journal-title":"Immunology"},{"key":"BFpr2016199_CR59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-3083.1991.tb02542.x","volume":"33","author":"N Lycke","year":"1991","unstructured":"Lycke N, Karlsson U, Sj\u00f6lander A, Magnusson KE. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol 1991;33:691\u20138.","journal-title":"Scand J Immunol"},{"key":"BFpr2016199_CR60","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/eji.1830220915","volume":"22","author":"N Lycke","year":"1992","unstructured":"Lycke N, Tsuji T, Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 1992;22:2277\u201381.","journal-title":"Eur J Immunol"},{"key":"BFpr2016199_CR61","first-page":"488","volume":"75","author":"M Vajdy","year":"1992","unstructured":"Vajdy M, Lycke NY. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 1992;75:488\u201392.","journal-title":"Immunology"},{"key":"BFpr2016199_CR62","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nbt1098-934","volume":"16","author":"T Arakawa","year":"1998","unstructured":"Arakawa T, Yu J, Chong DK, Hough J, Engen PC, Langridge WH. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat Biotechnol 1998;16:934\u20138.","journal-title":"Nat Biotechnol"},{"key":"BFpr2016199_CR63","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","volume":"94","author":"I Bergerot","year":"1997","unstructured":"Bergerot I, Ploix C, Petersen J, et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 1997;94:4610\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2016199_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1365-2249.2003.02255.x","volume":"134","author":"JS Petersen","year":"2003","unstructured":"Petersen JS, Bregenholt S, Apostolopolous V, et al. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin Exp Immunol 2003;134:38\u201345.","journal-title":"Clin Exp Immunol"},{"key":"BFpr2016199_CR65","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.2337\/diabetes.48.11.2150","volume":"48","author":"C Ploix","year":"1999","unstructured":"Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells. Diabetes 1999;48:2150\u20136.","journal-title":"Diabetes"},{"key":"BFpr2016199_CR66","doi-asserted-by":"publisher","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","volume":"91","author":"JB Sun","year":"1994","unstructured":"Sun JB, Holmgren J, Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 1994;91:10795\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2016199_CR67","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","volume":"93","author":"JB Sun","year":"1996","unstructured":"Sun JB, Rask C, Olsson T, Holmgren J, Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 1996;93:7196\u2013201.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2016199_CR68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/cimm.1998.1421","volume":"191","author":"TG Blanchard","year":"1999","unstructured":"Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol 1999;191:74\u201380.","journal-title":"Cell Immunol"},{"key":"BFpr2016199_CR69","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1084\/jem.188.12.2277","volume":"188","author":"TH Ermak","year":"1998","unstructured":"Ermak TH, Giannasca PJ, Nichols R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998;188:2277\u201388.","journal-title":"J Exp Med"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T09:52:15Z","timestamp":1692525135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":69,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFpr2016199"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.199","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]},"assertion":[{"value":"2 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}